Immediate Impact

2 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis
2023 Standout
2 intermediate papers

Works of Angela Sciandivasci being referenced

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
2013
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer
2012

Author Peers

Author Last Decade Papers Cites
Angela Sciandivasci 415 283 189 23 580
Winfried Schoenegg 346 235 191 24 620
Wen Wei 253 201 109 21 536
Yoshiaki Sagara 339 210 117 31 602
Bianca Lederer 397 332 114 39 619
Billie‐Jo M. Kerns 331 179 138 18 582
Mitsuharu Hirai 322 232 219 28 678
A.H. Honkoop 296 209 104 18 569
F. De Vita 401 219 193 35 680
In Ae Park 308 239 86 17 589
Preeti Sudheendra 332 341 121 21 609

All Works

Loading papers...

Rankless by CCL
2026